As humans continue to fight against numerous diseases, not the least of which is the latest COVID-19 pandemic, of huge concern to scientists are the health risks posed by obesity, linked to such chronic conditions as diabetes, heart disease, high blood pressure, and cancer, and the overuse of antibiotics, which can trigger antibiotic resistance and even the creation of "superbugs". There are reports of the emergence of “superbugs" which do not respond to all currently available antibiotics.


Fortunately, after years of dedicated efforts, PolyU research teams have made significant breakthroughs in addressing the above risks, through developing a new drug to cure multiple obesity-related diseases and repurposing existing drugs to fight “superbugs".